|
|
 |
|
Viewing report
|
|
|
|
Spectrum Pharmaceuticals, Inc. (SPPI) - Financial and Strategic SWOT Analysis Review
GlobalData, March 2012, Pages: 44
Spectrum Pharmaceuticals, Inc. (SPPI) - Financial and Strategic SWOT Analysis Review
Summary
Spectrum Pharmaceuticals, Inc., (Spectrum Pharmaceuticals), formerly known as NeoTherapeutics, Inc., is a fully integrated biotechnology company. It is engaged in the acquisition, development, and commercialization of diverse pipeline of late-stage clinical and commercial products with particualr focus on oncology. The company markets two drugs, namely, Zevalin and Fusilev and has two drugs, apaziquone and belinostat, in late stage development, along with a diversified pipeline of novel drug candidates. The company has developed a portfolio of neurology drug candidates which have completed in preclinical stages available for out-licensing. Spectrum Pharmaceutcials is headquartered in Henderson, Nevada, the US.
Spectrum Pharmaceuticals, Inc. Key Recent Developments
Mar 01, 2012: Spectrum Pharmaceuticals Reports Revenue Of $53m In Q4 2011
Jan 27, 2012: Spectrum Pharmaceuticals Announces Senior Mangement Changes
Oct 28, 2011: Spectrum Pharmaceuticals Reports Revenue Of $51m In Q3 2011
Sep 28, 2011: Spectrum Pharmaceuticals Appoints Brian Holzer As Executive Director Of Brand Management
Sep 23, 2011: Spectrum Pharmaceuticals To Present At Jefferies 2011 Global Healthcare Conference
This comprehensive SWOT profile of Spectrum Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Transdel Pharmaceuticals, Inc. (TDLPD) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
|
|
|
|
